The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: More Than a Numbers Game
Open accessAbstract
Regulatory T cells (Treg) play a dominant role in suppression of autoimmune pathology, as rescue of Treg number and/or function in model systems can both prevent and reverse disease. These findings have generated a series of studies addressing the role of defects in Treg number and function in human autoimmunity. However, demonstrating global defects in Treg of individuals diagnosed with autoimmune diseases has been challenging. These challenges are founded, in part, in the complexity of human autoimmune diseases in which various genetic factors and environmental triggers contribute to disease susceptibility. Moreover, contribution of failed Treg-mediated suppression to pathogenesis can extend to multiple mechanisms. In this article, we discuss what is known with respect to the number and function of CD4+FOXP3+ Treg in human autoimmunity, focusing on representative autoimmunediseases in which there are diverse Treg-mediated defects. We also highlight the need to better understand Treg plasticity and function in the context of autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
The Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,684
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher-Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,859
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., & Nomura, T. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00427.x · Cited by 1,555
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“Low expression of CD127 on CD4CD25 cells can more precisely identify stable FOXP3 Treg in control subjects (60, 61).”
BackgroundThornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y., & Shevach, E. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904028 · Cited by 1,382
Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martínez-Llordella, M., Ashby, M., Nakayama, M., Rosenthal, W., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1774 · Cited by 1,370
Natural versus adaptive regulatory T cells
Bluestone, J. A., & Abbas, A. K. (2003) · Nature Reviews Immunology · doi:10.1038/nri1032 · Cited by 1,323
The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley, J. B., Alarcón-Riquelme, M. E., Criswell, L. A., Jacob, C. O., Kimberly, R. P., Moser, K. L., Tsao, B. P., Vyse, T. J., & Langefeld, C. D. (2008) · Nature Genetics · doi:10.1038/ng.81 · Cited by 1,309
Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Höpner, S., Centonze, D., Bernardi, G., Dell'Acqua, M. L., et al. (2007) · Blood · doi:10.1182/blood-2006-12-064527 · Cited by 1,286
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., & Mauri, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040165 · Cited by 1,252
Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
Curotto de Lafaille, M. A., & Lafaille, J. J. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.002 · Cited by 1,055
Fontenot, J. D., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1179 · Cited by 950
Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes
Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M., & Tree, T. I. M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.92 · Cited by 861
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells
Valencia, X., Stephens, G., Goldbach-Mansky, R., Wilson, M., Shevach, E. M., & Lipsky, P. E. (2006) · Blood · doi:10.1182/blood-2005-11-4567 · Cited by 781
Phenotypical and functional specialization of FOXP3+ regulatory T cells
Campbell, D. J., & Koch, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri2916 · Cited by 773
Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
Tang, Q., Adams, J. Y., Penaranda, C., Melli, K., Piaggio, E., Sgouroudis, E., Piccirillo, C. A., Salomon, B. L., & Bluestone, J. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.016 · Cited by 729
Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant
Vang, T., Congia, M., Macis, M. D., Musumeci, L., Orrú, V., Zavattari, P., Nika, K., Tautz, L., Taskén, K., Cucca, F., et al. (2005) · Nature Genetics · doi:10.1038/ng1673 · Cited by 728
Peripheral and Intestinal Regulatory CD4+CD25high T Cells in Inflammatory Bowel Disease
Maul, J., Loddenkemper, C., Mundt, P., Berg, E., Giese, T., Stallmach, A., Zeitz, M., & Duchmann, R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.043 · Cited by 651
Zheng, S. G., Wang, J., Wang, P., Gray, J. D., & Horwitz, D. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2018 · Cited by 597
Valencia, X., Yarboro, C., Illei, G., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2579 · Cited by 594
Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?
Huehn, J., Polansky, J. K., & Hamann, A. (2009) · Nature Reviews Immunology · doi:10.1038/nri2474 · Cited by 526
MHC Class-II Molecules and Autoimmunity
Nepom, G. T., & Erlich, H. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.002425 · Cited by 519
Defective regulatory and effector T cell functions in patients with FOXP3 mutations
Bacchetta, R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25112 · Cited by 511
Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activityin vitro
Stephens, L. A., Mottet, C., Mason, D., & Powrie, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1247::aid-immu1247>3.0.co;2-m · Cited by 486
Vukmanovic-Stejic, M., Zhang, Y., Cook, J. E., Fletcher, J. M., McQuaid, A., Masters, J. E., Rustin, M. H. A., Taams, L. S., Beverley, P. C. L., Macallan, D. C., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28941 · Cited by 480
CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
Fletcher, J. M., Lonergan, R., Costelloe, L., Kinsella, K., Moran, B., O'Farrelly, C., Tubridy, N., & Mills, K. H. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901881 · Cited by 476
Dieckmann, D., Bruett, C. H., Ploettner, H., Lutz, M. B., & Schuler, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020642 · Cited by 467
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
Uhlig, H. H., Coombes, J., Mottet, C., Izcue, A., Thompson, C., Fanger, A., Tannapfel, A., Fontenot, J. D., Ramsdell, F., & Powrie, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5852 · Cited by 463
Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus
Miyara, M., Amoura, Z., Parizot, C., Badoual, C., Dorgham, K., Trad, S., Nochy, D., Debré, P., Piette, J.-C., & Gorochov, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8392 · Cited by 456
Haas, J., Hug, A., Viehöver, A., Fritzsching, B., Falk, C. S., Filser, A., Vetter, T., Milkova, L., Korporal, M., Fritz, B., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526065 · Cited by 449
Cao, D., Malmström, V., Baecher‐Allan, C., Hafler, D., Klareskog, L., & Trollmo, C. (2003) · European Journal of Immunology · doi:10.1002/immu.200390024 · Cited by 439
Lowe, C. E., Cooper, J. D., Brusko, T., Walker, N. M., Smyth, D. J., Bailey, R., Bourget, K., Plagnol, V., Field, S., Atkinson, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2102 · Cited by 424
Quantification of regulatory T cells in patients with systemic lupus erythematosus
Crispin, J. C., Martı́nez, A., & Alcocer-Varela, J. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00121-5 · Cited by 408
Indoleamine 2,3‐dioxygenase in T‐cell tolerance and tumoral immune escape
Katz, J. B., Muller, A. J., & Prendergast, G. C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00610.x · Cited by 398
Functional Defects and the Influence of Age on the Frequency of CD4+CD25+ T-Cells in Type 1 Diabetes
Brusko, T. M., Wasserfall, C. H., Clare-Salzler, M. J., Schatz, D. A., & Atkinson, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1407 · Cited by 398
Decreased FOXP3 levels in multiple sclerosis patients
Huan, J., Culbertson, N., Spencer, L., Bartholomew, R., Burrows, G. G., Chou, Y. K., Bourdette, D., Ziegler, S. F., Offner, H., & Vandenbark, A. A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20522 · Cited by 369
Venken, K., Hellings, N., Thewissen, M., Somers, V., Hensen, K., Rummens, J., Medaer, R., Hupperts, R., & Stinissen, P. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02690.x · Cited by 360
Genetic Variation in PTPN22 Corresponds to Altered Function of T and B Lymphocytes
Rieck, M., Arechiga, A., Onengut-Gumuscu, S., Greenbaum, C., Concannon, P., & Buckner, J. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4704 · Cited by 356
Self-citationMöttönen, M., Heikkinen, J., Mustonen, L., Isomäki, P., Luukkainen, R., & Lassila, O. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02754.x · Cited by 320
Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis
Flores-Borja, F., Jury, E. C., Mauri, C., & Ehrenstein, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806855105 · Cited by 312
Distinct Roles for the OX40-OX40 Ligand Interaction in Regulatory and Nonregulatory T Cells
Takeda, I., Ine, S., Killeen, N., Ndhlovu, L. C., Murata, K., Satomi, S., Sugamura, K., & Ishii, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3580 · Cited by 308
CD25+ cell depletion hastens the onset of severe disease in collagen‐induced arthritis
Morgan, M. E., Sutmuller, R. P. M., Witteveen, H. J., van Duivenvoorde, L. M., Zanelli, E., Melief, C. J. M., Snijders, A., Offringa, R., de Vries, R. R. P., & Toes, R. E. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11063 · Cited by 305
Schneider, A., Rieck, M., Sanda, S., Pihoker, C., Greenbaum, C., & Buckner, J. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7350 · Cited by 301
Self-citationAlterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis
Astier, A. L., Meiffren, G., Freeman, S., & Hafler, D. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29251 · Cited by 292
Long, S. A., Cerosaletti, K., Bollyky, P. L., Tatum, M., Shilling, H., Zhang, S., Zhang, Z.-Y., Pihoker, C., Sanda, S., Greenbaum, C., et al. (2010) · Diabetes · doi:10.2337/db09-0694 · Cited by 283
Self-citationVenken, K., Hellings, N., Broekmans, T., Hensen, K., Rummens, J.-L., & Stinissen, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6411 · Cited by 259
No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes
Brusko, T., Wasserfall, C., McGrail, K., Schatz, R., Viener, H. L., Schatz, D., Haller, M., Rockell, J., Gottlieb, P., Clare-Salzler, M., et al. (2007) · Diabetes · doi:10.2337/db06-1248 · Cited by 253
Haas, J., Fritzsching, B., Trübswetter, P., Korporal, M., Milkova, L., Fritz, B., Vobis, D., Krammer, P. H., Suri-Payer, E., & Wildemann, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1322 · Cited by 249
Maier, L. M., Lowe, C. E., Cooper, J., Downes, K., Anderson, D. E., Severson, C., Clark, P. M., Healy, B., Walker, N., Aubin, C., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000322 · Cited by 245
PTPN22: Setting thresholds for autoimmunity
Gregersen, P. K., Lee, H.-S., Batliwalla, F., & Begovich, A. B. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.009 · Cited by 229
Cutting Edge: Increased IL-17–Secreting T Cells in Children with New-Onset Type 1 Diabetes
Marwaha, A. K., Crome, S. Q., Panagiotopoulos, C., Berg, K. B., Qin, H., Ouyang, Q., Xu, L., Priatel, J. J., Levings, M. K., & Tan, R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001860 · Cited by 221
Booth, N. J., McQuaid, A. J., Sobande, T., Kissane, S., Agius, E., Jackson, S. E., Salmon, M., Falciani, F., Yong, K., Rustin, M. H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903781 · Cited by 220
Allograft rejection mediated by memory T cells is resistant to regulation
Yang, J., Brook, M. O., Carvalho-Gaspar, M., Zhang, J., Ramon, H. E., Sayegh, M. H., Wood, K. J., Turka, L. A., & Jones, N. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704397104 · Cited by 214
Zhang, L., Yang, X.-Q., Cheng, J., Hui, R.-S., & Gao, T.-W. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.11.008 · Cited by 211
CD4+CD25high regulatory T cells in human autoimmune diabetes
Putnam, A. L., Vendrame, F., Dotta, F., & Gottlieb, P. A. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.11.004 · Cited by 205
Feger, U., Luther, C., Poeschel, S., Melms, A., Tolosa, E., & Wiendl, H. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03271.x · Cited by 199
Chowdary Venigalla, R. K., Tretter, T., Krienke, S., Max, R., Eckstein, V., Blank, N., Fiehn, C., Dick Ho, A., & Lorenz, H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23556 · Cited by 196
Humrich, J. Y., Morbach, H., Undeutsch, R., Enghard, P., Rosenberger, S., Weigert, O., Kloke, L., Heimann, J., Gaber, T., Brandenburg, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903158107 · Cited by 194
IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity
Ochs, H. D., Gambineri, E., & Torgerson, T. R. (2007) · Immunologic Research · doi:10.1007/s12026-007-0022-2 · Cited by 176
Fritzsching, B., Oberle, N., Eberhardt, N., Quick, S., Haas, J., Wildemann, B., Krammer, P. H., & Suri-Payer, E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.32 · Cited by 175
4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells
Choi, B. K., Bae, J. S., Choi, E. M., Kang, W. J., Sakaguchi, S., Vinay, D. S., & Kwon, B. S. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003491 · Cited by 175
Maier, L. M., Anderson, D. E., Severson, C. A., Baecher-Allan, C., Healy, B., Liu, D. V., Wittrup, K. D., De Jager, P. L., & Hafler, D. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1541 · Cited by 175
Lee, J., Wang, L., Lin, Y., Yang, Y., Lin, D., & Chiang, B. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02306.x · Cited by 172
FOXP3: Not just for regulatory T cells anymore
Ziegler, S. F. (2007) · European Journal of Immunology · doi:10.1002/eji.200636929 · Cited by 170
Lawson, J. M., Tremble, J., Dayan, C., Beyan, H., Leslie, R. D. G., Peakman, M., & Tree, T. I. M. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03810.x · Cited by 168
The genetics of autoimmune diseases: a networked perspective
Baranzini, S. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.09.014 · Cited by 160
Baranwal, M., Putzki, N., Limmroth, V., Remus, R., Lindemann, M., Knop, D., Mueller, N., Hardt, C., Kreuzfelder, E., & Grosse‐Wilde, H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.08.003 · Cited by 160
Han, G., O’Neil-Andersen, N. J., Zurier, R. B., & Lawrence, D. A. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2008.05.007 · Cited by 154
Bollyky, P. L., Falk, B. A., Wu, R. P., Buckner, J. H., Wight, T. N., & Nepom, G. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0109001 · Cited by 153
Self-citationAn autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4+ T cells
Long, S., Cerosaletti, K. M., Wan, J. Y., Ho, J.-C., Tatum, M., Wei, S., Shilling, H. G., & Buckner, J. H. (2010) · Genes and Immunity · doi:10.1038/gene.2010.54 · Cited by 150
Self-citationUnraveling the Genetics of Autoimmunity
Zenewicz, L. A., Abraham, C., Flavell, R. A., & Cho, J. H. (2010) · Cell · doi:10.1016/j.cell.2010.03.003 · Cited by 149
Suárez, A., López, P., Gómez, J. M. F., & Gutiérrez, C. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.049924 · Cited by 146
Vargas-Rojas, M., Crispín, J. C., Richaud‐Patín, Y., & Alcocer-Varela, J. C. (2008) · Lupus · doi:10.1177/0961203307088307 · Cited by 128
FOXP3+ regulatory T cells: Current controversies and future perspectives
Banham, A. H., Powrie, F. M., & Suri‐Payer, E. (2006) · European Journal of Immunology · doi:10.1002/eji.200636459 · Cited by 126
Putheti, P., Pettersson, Å., Söderström, M. B., Link, H., & Huang, Y.-M. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000019780.93817.82 · Cited by 122
Tanaka, S., Maeda, S., Hashimoto, M., Fujimori, C., Ito, Y., Teradaira, S., Hirota, K., Yoshitomi, H., Katakai, T., Shimizu, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000848 · Cited by 118
Yates, J., Rovis, F., Mitchell, P., Afzali, B., Tsang, J. Y., Garin, M. I., Lechler, R. I., Lombardi, G., & Garden, O. A. (2007) · International Immunology · doi:10.1093/intimm/dxm047 · Cited by 116
TNF-α: An Activator of CD4+FoxP3+TNFR2+ Regulatory T Cells
Chen, X., & Oppenheim, J. J. (2010) · Current directions in autoimmunity · doi:10.1159/000289201 · Cited by 115
Michel, L., Berthelot, L., Pettré, S., Wiertlewski, S., Lefrère, F., Braudeau, C., Brouard, S., Soulillou, J., & Laplaud, D. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35365 · Cited by 110
Decrease of regulatory T cells in patients with systemic lupus erythematosus
Mellor‐Pita, S., Citores, M. J., Castejon, R., Tutor‐Ureta, P., Yebra-Bango, M., Andreu, J. L., & Vargas, J. A. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044974 · Cited by 109
Transcriptional regulation of IL-2 in health and autoimmunity
Crispín, J. C., & Tsokos, G. C. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.07.042 · Cited by 104
Regulation of Regulatory T Cells: Role of Dendritic Cells and Toll-Like Receptors
Kabelitz, D., Wesch, D., & Oberg, H. (2006) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v26.i4.10 · Cited by 102
Regulatory T cells overturned: the effectors fight back
Walker, L. S. K. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03053.x · Cited by 100
Swainson, L. A., Mold, J. E., Bajpai, U. D., & McCune, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903943 · Cited by 98
Regulatory T Cells Are Reduced During Anti-CD25 Antibody Treatment of Multiple Sclerosis
Oh, U., Blevins, G., Griffith, C., Richert, N. D., Maric, D., Lee, C. R., McFarland, H. F., & Jacobson, S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.16 · Cited by 98
Altered homeostasis of CD4+ FoxP3+regulatory T‐cell subpopulations in systemic lupus erythematosus
Suen, J., Li, H., Jong, Y., Chiang, B., & Yen, J. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02937.x · Cited by 94
Apoptosis of CD4+CD25high T Cells in Type 1 Diabetes May Be Partially Mediated by IL-2 Deprivation
Jailwala, P., Waukau, J., Glišić, S., Jana, S., Ehlenbach, S. J., Hessner, M. J., Alemzadeh, R., Matsuyama, S., Laud, P. W., Wang, X., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006527 · Cited by 93
Human regulatory T cells in autoimmune diseases
Cvetanovich, G. L., & Hafler, D. A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.08.012 · Cited by 88
A Mini Meta‐Analysis of Studies on CD4+CD25+ T cells in Human Type 1 Diabetes
Tree, T. I. M., Roep, B. O., & Peakman, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1375.002 · Cited by 77
Is FCRL3 a New General Autoimmunity Gene?
Chistiakov, D. A., & Chistiakov, A. P. (2007) · Human Immunology · doi:10.1016/j.humimm.2007.01.013 · Cited by 75
Oberg, H., Ly, T. T. H., Ussat, S., Meyer, T., Kabelitz, D., & Wesch, D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0804279 · Cited by 72
Zhang, B., Zhang, X., Tang, F., Zhu, L., & Liu, Y. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03686.x · Cited by 68
Yates, J., Whittington, A., Mitchell, P., Lechler, R. I., Lightstone, L., & Lombardi, G. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03665.x · Cited by 67
Wohlfert, E. A., & Clark, R. B. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.02.003 · Cited by 51
Long, S. A., Walker, M., Rieck, M., James, E. A., Kwok, W. W., Sanda, S., Pihoker, C., Greenbaum, C. J., Nepom, G. T., & Buckner, J. H. (2009) · European Journal of Immunology · doi:10.1002/eji.200838819 · Cited by 48
Self-citationFritzsching, B., Korporal, M., Haas, J., Krammer, P. H., Suri‐Payer, E., & Wildemann, B. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.09.006 · Cited by 28
Thompson, L. J., Valladao, A. C., & Ziegler, S. F. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003573 · Cited by 21
Cited by
Regulatory T Cells and Human Disease
Sakaguchi, S., Mikami, N., Wing, J. B., Tanaka, A., Ichiyama, K., & Ohkura, N. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041717 · Cited by 1,120
Immunopathogenic mechanisms of systemic autoimmune disease
Wahren-Herlenius, M., & Dörner, T. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60954-x · Cited by 593
Bailey-Bucktrout, S. L., Martinez-Llordella, M., Zhou, X., Anthony, B., Rosenthal, W., Luche, H., Fehling, H. J., & Bluestone, J. A. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.016 · Cited by 396
Ohkura, N., & Sakaguchi, S. (2020) · Cell Research · doi:10.1038/s41422-020-0324-7 · Cited by 353
Mechanisms of Inflammatory Responses in Obese Adipose Tissue
Sun, S., Ji, Y., Kersten, S., & Qi, L. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150623 · Cited by 306
Metadata
- Authors
- Long, S. A., & Buckner, J. H.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-09-01
- Volume
- 187
- Issue
- 5
- Pages
- 2061-2066
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1532322008
- Cited by
- 294
- References
- 102
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.